Denmark
The Danish Cancer Bank (DCB) is a clinical biobank collecting blood and tissue samples from Danish cancer patients, including more than 311,000 samples from over 57,000 individuals. The DCB is the result of a national collaborative initiative that aims to collect biological material across the entire population of Danish cancer patients, yielding data that reflects the full disease pathway for each individual.
| Name of the connected EIT Health partner: | Lasse Boding |
| Number of individuals: | Total 57,360 – 9,695 Blood packages – 6,849 Tissue packages – 1,206 Bone marrow packages |
| Biobank confirmed willingness to provide samples/data for EIT Health studies: | Yes |
| Contact person(s) and contact data (e-mail address, tel. no) for access purposes: |
Estrid Høgdall Estrid.hoegdall@regionh.dk |
| Number of samples: | Total 311,840 – 13,040 Blood packages – 10,950 Tissue packages – 1,337 Bone marrow packages |
| Sample types: | – Blood packages – Tissue packages – Bone marrow packages |
| Website: | Danish Cancer Bank |
| Type of biobank: | Clinical |
| If longitudinal the frequency: | Varies |
| Link to central portal to seek samples and data: | Danish Biobank Register www.biobanks.dk |
| Broad consent: | Yes |
| Option to recall donors: | No |
| Option to recall family members: | No |
| Link to operational procedures: | Nationwide SOPs |
| Storage: | Controlled storage |
| Compliance with international standards: | Aligned with international guidelines |
| Current ISO certificates: | Not available |
| Clinical data linked to samples: | Data on samples such as diagnosis codes and primary organ |
| Omics data available: | Not available |
| Data standards: | Not available |
| Data security rules: | Not available |
| Research support, what type of expertise?: | Knowledge about research, guidance on extractions and cohort selection |
| Core facility services; what type? Link?: | Not available |
| Queries from national health registers: | Capacity to perform analysis |
| IP rules, what is negotiable?: | Not available |
| Requirements to study results (access etc.): | Not available |
| Participant’s right to the information: | Not available |
| Number of access contracts with industry: | 2, but many studies where industry is involved |